Weight regain now has a timetable — and a Nature mouse study tests the limits of semaglutide enthusiasm
Read the Sunday Brief →

Study wrapper · #1149

Composition and Labelling Accuracy of Products Sold as Retatrutide in Australia.

Piatkowski T, Craven A, Cornell S, et al. Drug and alcohol review. 2026.

Editor's note

Retatrutide is not approved anywhere, which means every vial sold under that name comes from the grey market — and independent testing of what those vials contain is exactly the kind of evidence this beat lacks. This team has previously documented mislabeled and inaccurately dosed peptide products in Australia's unregulated supply. The abstract is not yet available, so we are noting the paper now and will report the composition findings once we can review the full text.

Plain-language abstract

Australian researchers analyzed what is actually inside products sold as retatrutide — a drug still in clinical trials with no approved commercial version — checking whether contents match the labels.